Jury Awards $3 Million in AndroGel Retrial
A jury in Illinois awarded $3 million to a man who suffered a heart attack after using AndroGel testosterone gel.
Lawyers Tell Jury in AndroGel Trial to Send a Message
Lawyers for a man who had a heart attack while using AndroGel testosterone gel told a federal jury in Illinois that the manufacturer, AbbVie Inc., won't change the way it sells AndroGel unless it faces intense financial pressure and a...
Testosterone Lawsuit Set for Trial in January 2018
A federal judge presiding over 6,000 testosterone lawsuits has scheduled the first trial involving Eli Lilly's Axiron for January 28, 2018.
$140 Million Awarded in AndroGel Testosterone Trial
A jury in Illinois has found AbbVie Inc. responsible for failing to warn about the heart attack risks of the "Low T" testosterone gel AndroGel.
Testosterone Ups Blood Clot Risk by 63% In First 6 Months
Men who start testosterone therapy are 63% more likely to have a Venous Thromboembolism (VTE) in the first 6 months of treatment, with the risk peaking at 3 months. Over 6,300 lawsuits have been filed by men who were injured...
FDA Issues Warning on Testosterone Health Risks
Men who abuse or become dependent on testosterone or anabolic steroids face a number of life-threatening health risks, according to the FDA.
No Benefits of Testosterone for ‘Low T’ Found in Clinical Trials: Study
Men who take testosterone supplements for cardiovascular, sexual and physical function aren’t likely to see any benefits, according to a new study published in the medical journal PLOS ONE.